• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Consensus statement on the use of clozapine during the COVID-19 pandemic.

作者信息

Siskind Dan, Honer William G., Clark Scott, Correll Christoph U., Hasan Alkomiet, Howes Oliver, Kane John M., Kelly Deanna L., Laitman Robert, Lee Jimmy, MacCabe James H., Myles Nick, Nielsen Jimmi, Schulte Peter F., Taylor David, Verdoux Helene, Wheeler Amanda, Freudenreich Oliver

机构信息

From the Metro South Addiction and Mental Health Service, Brisbane, Australia (Siskind); the University of Queensland, School of Clinical Medicine, Brisbane, Australia (Siskind, Myles); the Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada (Honer); the University of Adelaide, School of Medicine, Adelaide, Australia (Clark, Kane); the The Zucker Hillside Hospital, Department of Psychiatry, Northwell Health, Glen Oaks, NY, USA (Correll, Kane); the Zucker School of Medicine at Hofstra/ Northwell, Department of Psychiatry and Molecular Medicine, Hempstead, NY, USA (Correll); Charité Universitätsmedizin Berlin, Department of Child and Adolescent Psychiatry, Berlin, Germany (Correll); the Department of Psychiatry, Psychotherapy and Psychosomatics of the University Augsburg, Augsburg, Germany (Hassan); the Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK (Howes, MacCabe); the MRC London Institute of Medical Sciences, Hammersmith Hospital, London, UK (Howes); the Institute of Clinical Sciences (ICS), Faculty of Medicine, Imperial College London, London, UK (Howes); the Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore, MD, USA (Kelly); the Bronx Westchester Medical Group, New York, NY, USA (Laitman); the North Region & Department of Psychosis, Institute of Mental Health, Singapore (Lee); the Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore (Lee); the Mental Health Centre Copenhagen, Copenhagen University Hospital, Copenhagen (Nielsen); the Mental Health Service Noord-Holland- Noord, Alkmaar, The Netherlands (Schulte); the South London and Maudsley NHS Foundation Trust, Pharmacy Department, Maudsley Hospital, London, UK (Taylor); the University of Bordeaux, INSERM, Bordeaux Population Health Research Center, Bordeaux, France (Verdoux); the Menzies Health Institute Queensland, Griffith University, Brisbane, Australia (Wheeler); the MGH Schizophrenia Clinical and Research Program, Massachusetts General Hospital, Boston, MA, USA (Freudenreich); and the Harvard Medical School, Boston, MA, USA (Freudenreich)

出版信息

J Psychiatry Neurosci. 2020 Apr 3;45(4):200061. doi: 10.1503/jpn.200061.

DOI:10.1503/jpn.200061
PMID:32242646
Abstract
摘要

相似文献

1
Consensus statement on the use of clozapine during the COVID-19 pandemic.关于在2019冠状病毒病大流行期间使用氯氮平的共识声明。
J Psychiatry Neurosci. 2020 Apr 3;45(4):200061. doi: 10.1503/jpn.200061.

引用本文的文献

1
Evaluating Reduced Blood Monitoring Frequency and the Detection of Hematological Abnormalities in Clozapine-Treated Patients With Schizophrenia: A Chart Review Study From the COVID-19 Pandemic.评估氯氮平治疗的精神分裂症患者减少血液监测频率及血液学异常的检测:一项来自新冠疫情期间的病历回顾研究
Schizophr Bull. 2025 Mar 14;51(2):493-500. doi: 10.1093/schbul/sbae113.
2
Psychiatry in the aftermath of COVID-19.新冠疫情后的精神病学。
Rev Psiquiatr Salud Ment. 2020 Apr-Jun;13(2):105-110. doi: 10.1016/j.rpsm.2020.04.004. Epub 2020 Apr 23.
3
Clozapine Therapy and COVID-19: A Systematic Review of the Prevalence Rates, Health Outcomes, Hematological Markers, and Patient Perspectives.氯氮平治疗与 COVID-19:患病率、健康结局、血液学标志物及患者观点的系统评价。
Schizophr Bull. 2023 Jan 3;49(1):53-67. doi: 10.1093/schbul/sbac148.
4
Transient drop in the neutrophil count during COVID-19 regardless of clozapine treatment in patients with mental illness.患有精神疾病的患者在感染新冠病毒期间,无论是否接受氯氮平治疗,中性粒细胞计数都会出现短暂下降。
Rev Psiquiatr Salud Ment (Engl Ed). 2022 Apr-Jun;15(2):134-137. doi: 10.1016/j.rpsmen.2022.06.006.
5
The disquietude of clozapine continuation during the COVID-19 pandemic.在新冠疫情期间氯氮平持续治疗的不安状况
Health Sci Rep. 2022 Feb 7;5(2):e506. doi: 10.1002/hsr2.506. eCollection 2022 Mar.
6
Clozapine toxicity and coronavirus disease 2019: A case report.氯氮平中毒与2019冠状病毒病:一例报告。
Schizophr Res. 2022 Feb;240:184-185. doi: 10.1016/j.schres.2022.01.008. Epub 2022 Jan 10.
7
Starting clozapine in patients with schizophrenia during the ongoing pandemic.在当前大流行期间,为精神分裂症患者启动氯氮平治疗。
Schizophr Res. 2022 May;243:440-442. doi: 10.1016/j.schres.2021.07.004. Epub 2021 Jul 22.
8
Transient drop in the neutrophil count during COVID-19 regardless of clozapine treatment in patients with mental illness.新冠病毒疾病期间中性粒细胞计数短暂下降,与患有精神疾病的患者是否接受氯氮平治疗无关。
Rev Psiquiatr Salud Ment (Engl Ed). 2021 Jul 3;15(2):134-7. doi: 10.1016/j.rpsm.2021.06.002.
9
COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine.COVID-19 感染可导致服用氯氮平的患者中性粒细胞计数减少。
J Psychiatry Neurosci. 2021 Mar 11;46(2):E232-E237. doi: 10.1503/jpn.200208.
10
Toxicity of psychotropic drugs in patients with COVID-19: A systematic review.精神药物在 COVID-19 患者中的毒性:一项系统评价。
Gen Hosp Psychiatry. 2021 May-Jun;70:1-9. doi: 10.1016/j.genhosppsych.2021.02.006. Epub 2021 Feb 18.